Hospira, Inc. recalls Nalbuphine HCl Injection, 20 mg/mL, 10 mL Multiple-dose Fliptop Vial, Rx only, Hospira, Inc., Lake Forest, IL 60045, NDC

Recalled December 26, 2012 · FDA recall D-096-2013 · Hospira

Hazard

Lack of Assurance of Sterility: Complains of a loose crimp applied to the fliptop vial; and a missing stopper and flip cap were received and therefore sterility cannot be assured. · FDA Class II

Units

145,400 vials

Sold at

Nationwide and Puerto Rico.

Description

Lack of Assurance of Sterility: Complains of a loose crimp applied to the fliptop vial; and a missing stopper and flip cap were received and therefore sterility cannot be assured.

Product

Nalbuphine HCl Injection, 20 mg/mL, 10 mL Multiple-dose Fliptop Vial, Rx only, Hospira, Inc., Lake Forest, IL 60045, NDC 0409-1467-01

Manufacturer(s)

Hospira, Inc.

Source: U.S. Food and Drug Administration. Official recall notice on fda.gov →